Pulmonary arterial hypertension associated with congenital heart disease. [electronic resource]
Producer: 20130524Description: 328-37 p. digitalISSN:- 1600-0617
- Antihypertensive Agents -- therapeutic use
- Bosentan
- Clinical Trials as Topic
- Comorbidity
- Down Syndrome -- complications
- Eisenmenger Complex -- complications
- Endothelium, Vascular -- physiopathology
- Epoprostenol -- therapeutic use
- Health Behavior
- Heart Defects, Congenital -- complications
- Heart Transplantation
- Humans
- Hypertension, Pulmonary -- complications
- Lung Transplantation
- Oxygen Inhalation Therapy
- Phosphodiesterase 5 Inhibitors -- therapeutic use
- Piperazines -- therapeutic use
- Practice Guidelines as Topic
- Pulmonary Circulation -- physiology
- Purines -- therapeutic use
- Sildenafil Citrate
- Sulfonamides -- therapeutic use
- Sulfones -- therapeutic use
- Thrombosis -- etiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.